CA Life Sciences Assoc FAST Program | Argenta Advisors

Jul 27, 2017

Argenta is pleased to be a part of California Life Sciences Association (CLSA) and its efforts as the state’s largest and most influential life sciences advocacy and business leadership organization.

CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy.  Founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged, CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout California.
Argenta is also pleased to act as an advisor for the California Life Sciences Institute’s Fellows All-Star Team (FAST) Advisory Program for select entrepreneurs in the medical technology field.

CMS and Third-Party Payer Clinical Trial Reimbursement: Part 1 -Why

By Kris Munroe • 17 Jan, 2024
Consider seeking reimbursement for your medical technology’s clinical trial to help long-term commercialization efforts.
Are Medical Device Reimbursement Consultants Obsolete

Is A.I. Going to Make Medical Device Reimbursement Consultants Obsolete?

By Kris Munroe • 30 Aug, 2023
A short experiment by medical device reimbursement consultants with Chat GPT to see how useful it is for learning about medical device reimbursement strategy.
Inconsistency between payer messaging and marketing materials can challenge reimbursement strategy

Critical Marketing Considerations for Medical Device Manufactures Impacting Reimbursement Strategy

By Elizabeth Brown, MD • 11 Jan, 2023
Argenta relays how marketing messages to physicians and patients may prompt payers to prioritize medical technology to an evidence-based coverage policy.
More Posts
Share by: